IL2RA and cancer: While the clinical manifestations of COVID-19 in cancer patients are generally similar to those in non-cancer patients, cancer patients are more likely to experience dyspnea and exhibit higher levels of pro-inflammatory cytokines, such as TNF-α, IL-6, and IL-2R, as well as significant decreases in lymphocytes and T cells [12, 13].